December 26, 2024
Financial Assets

Why Viking Therapeutics could be ‘onto something pretty amazing’

Eli Lilly (LLY) and Novo Nordisk (NVO) have become hot stocks over the past year thanks to their blockbuster GLP-1 drugs to treat obesity. Over the last year, Lilly and Novo shares are up 72% and 44%, respectively. By market cap, Novo is the largest company in Europe while Lilly ranks eighth among US companies

Read More
Fixed Assets

Jiuyuan Gene seeks IPO cash for bet on weight-loss drugs – Bamboo Works

The developer of treatments for cancer and bone fractures is branching out into the weight-loss market, but faces strong competition there Key Takeaways: At present, Jiuyuan Gene relies heavily on a bone repair product, Guyoudao, for around half its revenue The company is developing a generic version of the weight-loss drug Semaglutide, which is undergoing

Read More